Ireland
--:--IST
Recruiting Observational

Transition From Pediatric to Adult Epilepsy Care

NCT06778772 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2023-06-01
Last updated
2025-01-16

Condition(s) studied

Epilepsy

Investigational drug(s) / intervention(s)

transition pathway to adult care services for epilepsy patients.

transition pathway to adult care services for epilepsy patients.: This proposal aims to create a coordinated and shared transition pathway between pediatric and adult epilepsy services, addressing the needs of patients with chronic conditions. The primary objective is to assess the readiness of both patients and their caregivers for the transition, by comparing the Transition Readiness Assessment (TRAQ) questionnaire results between the last pediatric neuropsychiatric visit and the first adult neurology visit. Secondary objectives include evaluating changes in emotional-behavioral issues and quality of life, using the CBCL, YSR, and PedsQoL questionnaires. Assessments will be conducted at both pediatric and adult epilepsy services. The ultimate goal of the transition protocol is to improve care and outcomes for adolescents and young adults during the transition, focusing on emotional-behavioral and psychosocial aspects, and to develop a best-practice model that could influence future guidelines.

Study summary

The goal of this observational study is to assess the preparation of the caregiver and the patient for the transition, by comparing the results of the Transition Readiness Assessment (TRAQ) questionnaire at the time of the last pediatric neuropsychiatric visit, which is then repeated at the first adult epilepsy neurology visit.

The assessments will be conducted at the last evaluation at the pediatric epilepsy service and repeated at the first visit to the adult epilepsy service.

Eligibility

Sex
ALL
Min age
17 Years
Max age
18 Years
Healthy volunteers
No
\*\*Inclusion Criteria:\*\* * Patients aged 17 or 18 years. * Diagnosed with focal or generalized epilepsy, regardless of etiology and neuropsychological, neuropsychiatric, or internal comorbidities. * Those for whom continued epileptology follow-up is required according to standard care guidelines. \*\*Exclusion Criteria:\*\* * Patients undergoing EEG only for the detection of EEG abnormalities without a diagnosis of epilepsy. * Patients for whom the last neuropsychiatric evaluation does not recommend continued epileptology follow-up (patients considered "cured" from epilepsy according to ILAE guidelines).

Primary outcome measure(s)

  • readiness for transition evaluated throughout Transition Readiness Assessment Questionnaire (TRAQ) — 1 year
    To evaluate the preparation of patients and caregivers for the transition process, the Transition Readiness Assessment Questionnaire (TRAQ) will be assessed, and scores will be compared across T0, T1, and T2. The TRAQ has a scale range from 0 to 5, where: 0 indicates insufficient readiness for transition; 5 indicates optimal readiness for transition. Higher scores indicate better preparation for the transition process, while lower scores suggest poorer readiness and a need for further support.

Trial sites (1)

FacilityCityRegionStatus
Child Neuropsichiatry Pavia Italy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06778772 on ClinicalTrials.gov ↗ ← All trials in Italy